JOAN CARTER: Open Payments
NPI 1376155044 · FREDERICKSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$686 in 7 payments from 7 companies in 2025. Trend: 2023 $125 · 2024 $337 · 2025 $686
Food & beverage: $667Education: $19
| Company | Payments | Amount |
|---|---|---|
| Vifor Pharma, Inc. | 1 | $125 |
| Lilly USA, LLC | 1 | $123 |
| ABBVIE INC. | 1 | $123 |
| Novo Nordisk Inc | 1 | $121 |
| Novartis Pharmaceuticals Corporation | 1 | $91 |
| AstraZeneca Pharmaceuticals LP | 1 | $84 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
Products named: Veltassa, MOUNJARO, QULIPTA, Wegovy, Vanrafia, TEZSPIRE, JARDIANCE.
Industry payments across VA — which companies pay providers there.
